• Publications
  • Influence
Increased Bone Turnover in Prepubertal, Pubertal, and Postpubertal Patients Receiving Carbamazepine
Summary:  Purpose: To study the markers of bone turnover in epilepsy patients in the different stages of the pubertal growth before and after the beginning of carbamazepine (CBZ) monotherapy.
Increased bone turnover in epileptic patients treated with carbamazepine
It is demonstrated that carbamazepine induces an increase of bone turnover and higher values of markers of bone formation and of bone resorption are found in patients than in controls. Expand
Metabolic and endocrine effects of valproic acid chronic treatment
The metabolic and endocrine effects of VPA chronic treatment in patients with epilepsy and an elevation in the levels of uric acid and homocysteine, together with oxidative stress, may contribute to atherosclerotic risk in patients under long-term therapy with VPA. Expand
Panayiotopoulos syndrome: a consensus view
It is concluded that PS is a common idiopathic, benign seizure disorder of childhood, which should be classified as an autonomic epilepsy, rather than an occipital epilepsy. Expand
Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine
It is demonstrated that prolonged treatment with VPA and CBZ increases plasma concentrations of Hcy and a significant decrease of serum folate and plasma PLP after 1 year of therapy. Expand
Autonomic Neuropathy in Diabetes Mellitus
The present review summarizes the latest knowledge regarding clinical presentation, epidemiology, pathogenesis, and management of DAN, with some mention to childhood and adolescent population. Expand
Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): An open-label, parallel group trial
Preliminary data from an open, parallel group study suggest that levetiracetam and oxcarbazepine may be potentially effective and well tolerated drugs for children with BECTS who require treatment. Expand
Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid
If valproic acid treatment in epileptic patients in whom obesity develops modifies serum levels of insulin and leptin, 40 female patients with epilepsy were evaluated and 15 patients were obese and showed higher serum leptin and insulin levels than patients who did not gain weight. Expand
Attention deficit hyperactivity disorder in children with epilepsy
In epileptic children with symptoms of ADHD, treatment might become a challenge for child neurologists, who are forced to prescribe drugs combinations, to improve the long-term cognitive and behavioral prognosis. Expand